CELLCODEX TECHNOLOGY LIMITED

Active Cambridge

Research and experimental development on biotechnology

Research and experimental development on biotechnology
C

CELLCODEX TECHNOLOGY LIMITED

Research and experimental development on biotechnology

Founded 7 Jul 2025 Active Cambridge, England website.com
Research and experimental development on biotechnology
Accounts Due 7 Apr 2027 10 months remaining
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

69 Milton Road Cambridge CB4 1XA England

Website

www.example.com

Full company profile for CELLCODEX TECHNOLOGY LIMITED (16564418), an active company based in Cambridge, England. Incorporated 7 Jul 2025. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 31 July 2026
Due by 7 April 2027 10 months remaining

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 2,000,000 Shares £2 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Sept 20252,000,000£2£0

Officers

Officers

3 active
Status
Belgard, Tildon Grant, DrDirectorAmericanUnited States4029 Apr 2026Active
Emmanouil MetzakopianDirectorGreekEngland437 Jul 2025Active
Thomas Andrew WeaverDirectorBritishUnited Kingdom637 Jul 2025Active

Shareholders

Shareholders (2)

Thomas Weaver
50.0%
1
Emmanouil Metzakopian
50.0%
1

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Emmanouil Metzakopian

Greek

Active
Notified 7 Jul 2025
Residence England
DOB June 1982
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Thomas Andrew Weaver

British

Active
Notified 7 Jul 2025
Residence England
DOB August 1962
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Dr Tildon Grant Belgard

American

Active
Notified 15 Apr 2026
Residence United States
DOB May 1986
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Dr Thomas Andrew Weaver

Ceased 15 Apr 2026

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 May 2026ResolutionResolutions
30 Apr 2026OfficersAppointment of Mr Ravi Nataraj Moorthy as director on 29 Apr 2026
30 Apr 2026OfficersAppointment of Dr Tildon Grant Belgard as director on 29 Apr 2026
23 Apr 2026Persons With Significant ControlTildon Grant Belgard notified as a person with significant control
23 Apr 2026Persons With Significant ControlCessation of Thomas Andrew Weaver as a person with significant control on 15 Apr 2026
13 May 2026 Resolution

Resolutions

30 Apr 2026 Officers

Appointment of Mr Ravi Nataraj Moorthy as director on 29 Apr 2026

30 Apr 2026 Officers

Appointment of Dr Tildon Grant Belgard as director on 29 Apr 2026

23 Apr 2026 Persons With Significant Control

Tildon Grant Belgard notified as a person with significant control

23 Apr 2026 Persons With Significant Control

Cessation of Thomas Andrew Weaver as a person with significant control on 15 Apr 2026

Recent Activity

Latest Activity

Resolutions

1 days ago on 13 May 2026

Appointment of Mr Ravi Nataraj Moorthy as director on 29 Apr 2026

2 weeks ago on 30 Apr 2026

Appointment of Dr Tildon Grant Belgard as director on 29 Apr 2026

2 weeks ago on 30 Apr 2026

Tildon Grant Belgard notified as a person with significant control

3 weeks ago on 23 Apr 2026

Cessation of Thomas Andrew Weaver as a person with significant control on 15 Apr 2026

3 weeks ago on 23 Apr 2026